Mustang Stock Buy Hold or Sell Recommendation

MBIO
 Stock
  

USD 0.51  0.04  8.51%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Mustang Bio is 'Cautious Hold'. Macroaxis provides Mustang Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MBIO positions. The advice algorithm takes into account all of Mustang Bio's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Mustang Bio's buy-and-hold perspective. Additionally, see Mustang Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Mustang and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Mustang Bio.

Execute Mustang Bio Buy or Sell Advice

The Mustang recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mustang Bio. Macroaxis does not own or have any residual interests in Mustang Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mustang Bio's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Mustang BioBuy Mustang Bio
Strong Sell

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Financial Strenth (F Score)

Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Mustang Bio has a Mean Deviation of 3.18, Standard Deviation of 4.54 and Variance of 20.62
We provide investment recommendation to complement the last-minute expert consensus on Mustang Bio. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Mustang Bio is not overpriced, please verify all Mustang Bio fundamentals, including its total debt and the relationship between the short ratio and current liabilities . As Mustang Bio appears to be a penny stock we also strongly suggest to check its price to earning numbers.

Mustang Bio Trading Alerts and Improvement Suggestions

Mustang Bio generated a negative expected return over the last 90 days
Mustang Bio has some characteristics of a very speculative penny stock
Mustang Bio has high historical volatility and very poor performance
Net Loss for the year was (66.37 M) with profit before overhead, payroll, taxes, and interest of 0.
Mustang Bio currently holds about 107.37 M in cash with (53.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mustang Bio has a frail financial position based on the latest SEC disclosures
Roughly 20.0% of the company outstanding shares are owned by corporate insiders

Mustang Bio Returns Distribution Density

The distribution of Mustang Bio's historical returns is an attempt to chart the uncertainty of Mustang Bio's future price movements. The chart of the probability distribution of Mustang Bio stock daily returns describes the distribution of returns around its average expected value. We use Mustang Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mustang Bio returns is essential to provide solid investment advice for Mustang Bio.
Mean Return-0.22Value At Risk-6.52
Potential Upside8.51Standard Deviation4.54
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mustang Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Mustang Bio Cash Flow Accounts

201720182019202020212022 (projected)
Net Cash Flow or Change in Cash and Cash Equivalents7.98 M(18.51 M)45.44 M36.39 M11.81 M16.89 M
Issuance Purchase of Equity Shares50.3 M181 K54.14 M97.38 M72.23 M67.85 M
Net Cash Flow from Financing49.98 M181 K65.12 M78.12 M70.85 M76.44 M
Net Cash Flow from Operations(12.95 M)(19.24 M)(33.58 M)(37.32 M)(53.67 M)(55.08 M)

Mustang Bio Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Mustang Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Mustang Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Mustang stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.3
β
Beta against NYSE Composite1.11
σ
Overall volatility
4.67
Ir
Information ratio -0.06

Mustang Bio Volatility Alert

Mustang Bio exhibits very low volatility with skewness of 0.24 and kurtosis of 1.14. However, we advise investors to further study Mustang Bio technical indicators to ensure that all market info is available and is reliable. Mustang Bio is a potential penny stock. Although Mustang Bio may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Mustang Bio. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Mustang instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Mustang Bio Fundamentals Vs Peers

Comparing Mustang Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mustang Bio's direct or indirect competition across all of the common fundamentals between Mustang Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mustang Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mustang Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Mustang Bio by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Mustang Bio to competition
FundamentalsMustang BioPeer Average
Return On Equity(0.84) %(0.31) %
Return On Asset(0.39) %(0.14) %
Current Valuation(7.47 M)16.62 B
Shares Outstanding106.46 M571.82 M
Shares Owned by Insiders20.42 %10.09 %
Shares Owned by Institutions14.08 %39.21 %
Number of Shares Shorted558.33 K4.71 M
Price to Earning(11.40) X28.72 X
Price to Book0.82 X9.51 X
EBITDA(64.42 M)3.9 B
Net Income(66.37 M)570.98 M
Cash and Equivalents107.37 M2.7 B
Cash per Share1.01 X5.01 X
Total Debt29.01 M5.32 B
Debt to Equity0.35 %48.70 %
Current Ratio9.96 X2.16 X
Book Value Per Share0.60 X1.93 K
Cash Flow from Operations(53.67 M)971.22 M
Short Ratio1.66 X4.00 X
Earnings Per Share(0.77) X3.12 X
Target Price5.0
Number of Employees10218.84 K
Beta1.63-0.15
Market Capitalization54.74 M19.03 B
Total Asset125.17 M29.47 B
Retained Earnings(128.76 M)9.33 B
Working Capital38.44 M1.48 B
Current Asset42.37 M9.34 B
Current Liabilities3.93 M7.9 B
Z Score-5.58.72
Net Asset125.17 M
   Sale by Achenbach Brian of 3033 shares of Mustang Bio [view details]

Mustang Bio Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mustang . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Mustang Bio Buy or Sell Advice

When is the right time to buy or sell Mustang Bio? Buying financial instruments such as Mustang Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 (projected)
Accounts Payable4.07 M3.34 M
Receivables42.55 K63.79 K

Use Investing Ideas to Build Portfolios

In addition to having Mustang Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Investing Thematic Idea Now

Investing
Investing Theme
Companies involved in money management and investment banking services. The Investing theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
View All  Next Launch
Additionally, see Mustang Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for analysis

When running Mustang Bio price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
54.7 M
Return On Assets
(0.39) 
Return On Equity
(0.84) 
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Mustang Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.